Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pulmonary Resistance”

808 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 808 results

Not applicableLooking for participantsNCT05017766
What this trial is testing

NCCR AntiResist:: New Approaches to Combat Antibiotic-resistant Bacteria

Who this might be right for
Antimicrobial Resistance (AMR)
University Hospital, Basel, Switzerland 8,000
Testing effectiveness (Phase 2)UnknownNCT00663637
What this trial is testing

Removal of Endotracheal Tube Secretions Comprehensively Until Extubation

Who this might be right for
Mechanical VentilationPneumonia
O. M. Neotech, Inc. 30
Testing effectiveness (Phase 2)Study completedNCT01807546
What this trial is testing

Oral Rigosertib for Squamous Cell Carcinoma

Who this might be right for
Head and Neck Squamous Cell CarcinomaAnal Squamous Cell CarcinomaLung Squamous Cell Carcinoma+4 more
Traws Pharma, Inc. 64
Not applicableStudy completedNCT00779077
What this trial is testing

Cystic Fibrosis (CF) Flow Rates Study

Who this might be right for
Cystic Fibrosis
Syntara 25
Early research (Phase 1)Ended earlyNCT06264921
What this trial is testing

A Study With NKT3447 for Adults With Advanced/Metastatic Solid Tumors

Who this might be right for
Solid TumorSolid Tumor, AdultAdvanced Solid Tumor+26 more
NiKang Therapeutics, Inc. 23
Large-scale testing (Phase 3)Ended earlyNCT00307099
What this trial is testing

Comparative Antibiotic Therapy for Subjects With Pulmonary Infiltrates in the ICU

Who this might be right for
Bacterial Infection
National Institute of Allergy and Infectious Diseases (NIAID) 460
Early research (Phase 1)Looking for participantsNCT05353439
What this trial is testing

Testing of Tazemetostat in Combination With Topotecan and Pembrolizumab in Patients With Recurrent Small Cell Lung Cancer

Who this might be right for
Extensive Stage Lung Small Cell CarcinomaLimited Stage Lung Small Cell CarcinomaPlatinum-Resistant Lung Small Cell Carcinoma+3 more
National Cancer Institute (NCI) 60
Not applicableStudy completedNCT01354067
What this trial is testing

Single Limb Resistance Training in Patients With Chronic Obstructive Pulmonary Disease (COPD)

Who this might be right for
Pulmonary Disease, Chronic Obstructive
Umeå University 44
Not applicableStudy completedNCT02780219
What this trial is testing

Chronic Obstructive Pulmonary Disorder and Acute Exercise

Who this might be right for
Pulmonary Disease, Chronic Obstructive
Texas A&M University 57
Not applicableEnrolling By InvitationNCT06647836
What this trial is testing

The Therapeutic Effect of Immunotherapy in Patients With Advanced Lung Squamous Carcinoma

Who this might be right for
Squamous Cell Lung Cancer
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 1,000
Large-scale testing (Phase 3)Looking for participantsNCT06472245
What this trial is testing

Trial of Therapeutic Cancer Vaccine OSE2101 in Patients With Non-Small Cell Lung Cancer and Secondary Resistance to Immune Checkpoint Inhibitor

Who this might be right for
Patients With Non-Small Cell Lung Cancer
OSE Immunotherapeutics 363
Not applicableLooking for participantsNCT06924177
What this trial is testing

UTSW NORC Pilot Spinal Cord Injury Dietary Program

Who this might be right for
Obesity and Obesity-related Medical ConditionsSpinal Cord Injury, Chronic
University of Texas Southwestern Medical Center 20
Testing effectiveness (Phase 2)Study completedNCT03693612
What this trial is testing

GSK3359609 Plus Tremelimumab for the Treatment of Advanced Solid Tumors

Who this might be right for
Neoplasms
GlaxoSmithKline 26
Early research (Phase 1)Study completedNCT04176328
What this trial is testing

Open-label, Dose-escalation Study to Evaluate the Pharmacokinetics of Inhaled Teicoplanin in Cystic Fibrosis Patients

Who this might be right for
Cystic Fibrosis
Neupharma Srl 12
Large-scale testing (Phase 3)Study completedNCT02959749
What this trial is testing

Osimertinib or Docetaxel-bevacizumab as Third-line Treatment in EGFR T790M Mutated Non-Small Cell Lung Cancer

Who this might be right for
Progression Free Survival
Qingdao Central Hospital 147
Not applicableStudy completedNCT02860728
What this trial is testing

Resistance Training to Prehabilitate Patients With Chronic Obstructive Pulmonary Disease

Who this might be right for
Chronic Obstructive Pulmonary Disease
University of British Columbia 25
Not applicableStudy completedNCT01130714
What this trial is testing

Resistance Training in Lung Cancer Patients on Chemotherapy

Who this might be right for
InflammationLung Cancer
East Carolina University 15
Large-scale testing (Phase 3)Study completedNCT03181932
What this trial is testing

AeroVanc in the Treatment of Methicillin-resistant Staphylococcus Aureus Infection in Patients With Cystic Fibrosis

Who this might be right for
MRSACystic Fibrosis
Savara Inc. 188
Early research (Phase 1)Study completedNCT01772004
What this trial is testing

Avelumab in Metastatic or Locally Advanced Solid Tumors (JAVELIN Solid Tumor)

Who this might be right for
Solid Tumors
EMD Serono Research & Development Institute, Inc. 1,756
Not applicableNot Yet RecruitingNCT06605352
What this trial is testing

Clinical Impact of Rapid Molecular Testing for Pathogens in Patients With Severe Acute Respiratory Illness : A Pragmatic Trial

Who this might be right for
Community-Acquired Pneumonia (CAP)Pneumonia
National Taiwan University Clinical Trial Center 800
Load More Results